Synergy
NeuroPsychiatry
CV
Mauli Verma, MD
Education/Work Experience
Clinical Assistant Professor of Psychiatry, 2017- March 2021
Western Michigan Homer Stryker School of Medicine
Staff Psychiatrist, 5/2009 – 3/2021
Integrated Services of Kalamazoo
-
Conducted a comprehensive Psychiatric evaluation and prepared a diagnostic formulation using current DSM criteria; prescribed any needed psychotropic medications
-
Conducted emergency mental health evaluations to assess an individual’s immediate needs to assure their safety
-
Prepared a treatment plan, centered to an individual’s needs, including input from other treatment team members such as a Psychologist or Social worker
-
Taught 3rd Year Family Medicine Residents
Resident Physician, 7/2004 -12/2008
MSU/Kalamazoo Center for Medical Studies, Department of Psychiatry
Resident Physician, 7/2000 -9/2002
Nandanvan Psychiatric Hospital, Ahmedabad, India
Clinical Research Associate, 3/1999 -3/2000
Psychiatric Clinical Research Center
Department of Psychiatry, University of Illinois, Chicago, Illinois
-
Trained in standard Psychiatric rating scale administration
-
Researched Pharmacological strategies in severe Psychiatric disorders
Inpatient Resident Physician, 11/1993 -6/1998
Nandanvan Psychiatric Hospital, Ahmedabad, India
​
-
Diagnostics and inpatient care under the supervision of a Senior Psychiatrist
Medical School, 9/1987 - 9/1993
Baroda Medical College, M.S. University, Baroda, India
Publications
Deposition of 7-Aminoflunitrazepam and Flunitrazepam in Hair after a Single Dose of Rohypnol.
Journal of Forensic Sciences, September 2001; 46(5): 1143-51
Negrusz A., Moore C.M., Hinkel K.B., Stockham T.L., Verma M., Strong M.J., Janicak P.G.
Antipsychotics in the Treatment of Mood Disorders, Part II
International Drug Therapy Newsletter, November 1999
Ed: Frank J. Ayd Jr., M.D. Philip Janicak, Brian Martis and Mauli Verma
Antipsychotics in the Treatment of Mood Disorders, Part I
International Drug Therapy Newsletter, October 1999
Ed: Frank J. Ayd Jr., M.D. Philip Janicak, Brian Martis and Mauli Verma.
Abstracts
Repetitive Transcranial Magnetic Stimulation versus Electroconvulsive Therapy for Major Depressive Episode.
Submitted to the APA annual meeting, May 13-19, 2000, Chicago, Illinois.
Janicak P.G., Martis B., Krasuski J, Beedle D., Sharma R., Verma M. and Chase C.
Cognitive Effects of Repetitive Transcranial Magnetic Stimulation in Depressed Patients.
Submitted to the APA annual meeting, May 13-19, 2000, Chicago, Illinois.
Martis B., Carson V., Sharma R., Martin E., Janicak P.G., Verma M. and Chase C.
Research Experience
OASIS: Observation Study of LAIs in Schizophrenia.(Jan 2020-Present)
Principal Investigator: Mauli Verma, M.D.
Clinical Study Protocol- ALK3831-A307-To evaluate the Effect of ALKS 3831 compared to Olanzapine on Body weight in young adults with Schizophrenia, or Bipolar I Disorder, who are early in their illness.(8/2017 – Present)
Principal Investigator: Mauli Verma, M.D.
A New Study with Lundbeck, Interventional, Randomized, Double-Blind, Active-Controlled Study of the Efficacy Lu AF35700 in Patients with Early-in-Disease or Late-in-Disease Treatment-Resistant Schizophrenia. (8/2017 - 2019)
Principal Investigator: Mauli Verma, M.D.
Evaluation of the Clinical Utility of Pharmacogenomic Testing in Community Mental Health Patients in Kalamazoo, Michigan (2016)
Principal Investigator: Mauli Verma, M.D.
Mother’s Mind Matters Direct Impact Study (2008)
MSU/KCMS Psychiatry, Kalamazoo MI
Ruqiya Shama Tareen, M.D., Michael Liepman, M.D., Catherine L. Kothari, M.A.
Co-Investigator: Mauli Verma, M.D.
Detection of Date Rape Drugs (Flunitrazepam) in Hair and Urine (2000)
Psychiatric Clinical Research Center, University of Illinois, Chicago IL
Adam Negrusz, Ph.D., Philip Janicak, M.D. and Mauli Verma, M.D.
Informed Consent Process of Psychiatric Research (2000)
Psychiatric Clinical Research Center, University of Illinois, Chicago IL
Russ Omens, Psy. D., Philip Janicak, M.D., and Mauli Verma, M.D.